Log In
Print
BCIQ
Print
Print this Print this
 

Seven-day contraceptive patch (AG200-15) (formerly AG-200-15)

Also known as: Twirla, estradiol/levonorgestrel (Agile Patch)

  Manage Alerts
Collapse Summary General Information
Company Agile Therapeutics Inc.
DescriptionOnce-weekly transdermal patch containing low-dose ethinyl estradiol and levonorgestrel
Molecular Target Estrogen receptor ; Progesterone receptor
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationContraception
Indication DetailsContraception
Regulatory Designation

U.S. - Undisclosed Review (Contraception)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today